ZICCUM AB engages Emerging Viral Diseases unit of Aix-Marseille University to develop dry viruses and vaccines, strengthening Ziccum’s future IP portfolio
Lund, 19th December 2019. The Emerging Virus Unit (Unité des Virus Émergents) is one of the world’s leading virology laboratories. Ziccum has now engaged UVE to use Ziccum’s technology to develop and formulate vaccines and viruses as dry powders, boosting global access to them and making them significantly faster and cheaper to transport. This collaboration will significantly strengthen Ziccum’s IP portfolio.“Underimmunisation has never been more urgent” says Ziccum CEO Göran Conradson “this decision by Unité des virus émergents (UVE) to collaborate and develop the use of our technology to